[Short Educational Video] CMIC Group Released C-CAST: Executive Interview, Philippe Auvaro
- Recent changes and current opportunities in Japan’s Pharmaceutical market
- CMIC’s IPM (Innovative Pharma Model)

[Short Educational Video] CMIC Group Released Two C-CASTs on;
- Expedited Review Programs in Japan
- In-Country Clinical Caretaker (ICCC) for Clinical Trials in Japan

OrphanPacific Inc. measures to continue to serve the community while respecting the instructions from the government of the COVID-19

Response and Support During COVID-19 Pandemic
(Will be linked to CMIC Group website)

[Webinar Archive Available] Orphan drug development in Japan - How can we accelerate rare disease patients’ access to therapies? -

OrphanPacific Inc. measures to contain the further spread of the new corona-virus

Learn More about Japanese Market Entry